Free Trial

Haemonetics (HAE) News Today

Haemonetics logo
$69.99 +0.98 (+1.42%)
Closing price 06/18/2025 03:59 PM Eastern
Extended Trading
$70.05 +0.06 (+0.08%)
As of 06/18/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HAE Latest News

Brokerages Set Haemonetics Co. (NYSE:HAE) PT at $97.89
Haemonetics Corporation stock logo
Haemonetics Co. (NYSE:HAE) Given Average Recommendation of "Moderate Buy" by Brokerages
Haemonetics Co. (NYSE:HAE - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation, six h
Haemonetics Corporation stock logo
Fort Washington Investment Advisors Inc. OH Acquires 242,956 Shares of Haemonetics Co. (NYSE:HAE)
Fort Washington Investment Advisors Inc. OH grew its position in Haemonetics Co. (NYSE:HAE - Free Report) by 88.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 517,086 shares of the medical instruments
Haemonetics Corporation stock logo
Harbor Capital Advisors Inc. Sells 15,822 Shares of Haemonetics Co. (NYSE:HAE)
Harbor Capital Advisors Inc. cut its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 31.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 34,532 shares of the medical instruments suppl
Q1 EPS Estimates for Haemonetics Lowered by Zacks Research
Haemonetics Corporation stock logo
Zacks Research Decreases Earnings Estimates for Haemonetics
Haemonetics Co. (NYSE:HAE - Free Report) - Analysts at Zacks Research decreased their Q1 2026 earnings per share estimates for shares of Haemonetics in a report issued on Thursday, June 5th. Zacks Research analyst R. Department now expects that the medical instruments supplier will post earnings
Haemonetics Corporation stock logo
GAMMA Investing LLC Raises Position in Haemonetics Co. (NYSE:HAE)
GAMMA Investing LLC boosted its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 11,225.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,667 shares of the medical instruments supplier's stock a
Haemonetics Corporation stock logo
QV Investors Inc. Acquires New Stake in Haemonetics Co. (NYSE:HAE)
QV Investors Inc. bought a new position in Haemonetics Co. (NYSE:HAE - Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 11,240 shares of the medical instruments supplier's stock, valued at appr
Haemonetics Corporation stock logo
Q3 EPS Estimates for Haemonetics Decreased by Zacks Research
Haemonetics Co. (NYSE:HAE - Free Report) - Equities researchers at Zacks Research reduced their Q3 2026 earnings per share estimates for shares of Haemonetics in a note issued to investors on Wednesday, May 28th. Zacks Research analyst R. Department now expects that the medical instruments suppli
Haemonetics Corporation stock logo
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stake in Haemonetics Co. (NYSE:HAE)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 65.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 147,087
Haemonetics Corporation stock logo
Q1 EPS Estimates for Haemonetics Reduced by Zacks Research
Haemonetics Co. (NYSE:HAE - Free Report) - Zacks Research reduced their Q1 2026 earnings per share (EPS) estimates for shares of Haemonetics in a research note issued on Wednesday, May 28th. Zacks Research analyst R. Department now anticipates that the medical instruments supplier will post earni
Haemonetics Corporation stock logo
42,722 Shares in Haemonetics Co. (NYSE:HAE) Purchased by Confluence Investment Management LLC
Confluence Investment Management LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 42,722 shares of the
Haemonetics Corporation stock logo
Two Sigma Investments LP Lowers Stock Position in Haemonetics Co. (NYSE:HAE)
Two Sigma Investments LP lessened its holdings in Haemonetics Co. (NYSE:HAE - Free Report) by 24.1% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 58,799 shares of the medical instruments supplier's stock after selling 18,675 shares during the period. Two Sigma
Haemonetics Corporation stock logo
Man Group plc Has $242,000 Position in Haemonetics Co. (NYSE:HAE)
Man Group plc lessened its position in Haemonetics Co. (NYSE:HAE - Free Report) by 87.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,098 shares of the medical instruments supplier's stock after selling 21,511 shares during the pe
Haemonetics Corporation stock logo
Haemonetics Co. (NYSE:HAE) Shares Sold by Nuveen Asset Management LLC
Nuveen Asset Management LLC reduced its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 161,452 shares of the medical instrum
Haemonetics Corporation stock logo
Millennium Management LLC Decreases Position in Haemonetics Co. (NYSE:HAE)
Millennium Management LLC cut its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 33.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 162,307 shares of the medical instruments s
Haemonetics Corporation stock logo
ProShare Advisors LLC Increases Stock Position in Haemonetics Co. (NYSE:HAE)
ProShare Advisors LLC boosted its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 40.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,486 shares of the medical instruments supplier's stock afte
Haemonetics Corporation stock logo
D. E. Shaw & Co. Inc. Trims Position in Haemonetics Co. (NYSE:HAE)
D. E. Shaw & Co. Inc. cut its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 99.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 18,237 shares of the medical instruments supplier's stock after selling 3,281,763 shares during the period. D. E
Haemonetics Corporation stock logo
Nomura Holdings Inc. Invests $519,000 in Haemonetics Co. (NYSE:HAE)
Nomura Holdings Inc. purchased a new position in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 6,652 shares of the medical instruments supplier's stock, valued at approximately $519,000. A number of
Haemonetics Corporation stock logo
Ameriprise Financial Inc. Sells 132,854 Shares of Haemonetics Co. (NYSE:HAE)
Ameriprise Financial Inc. lessened its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 56.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 102,675 shares of the medical instruments supplier's stock after selling 132,8
Haemonetics Corporation stock logo
Haemonetics Co. (NYSE:HAE) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Haemonetics Co. (NYSE:HAE - Get Free Report) have been assigned an average rating of "Moderate Buy" from the nine ratings firms that are presently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has assigned a hold reco
Haemonetics Corporation stock logo
Lazard Asset Management LLC Sells 7,509,830 Shares of Haemonetics Co. (NYSE:HAE)
Lazard Asset Management LLC trimmed its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 99.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,936 shares of the medical instruments supplier's stock after selling
Haemonetics Corporation stock logo
Haemonetics Co. (NYSE:HAE) Shares Bought by Janus Henderson Group PLC
Janus Henderson Group PLC lifted its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 29.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 60,436 shares of the medical instruments supplier's stock after
Haemonetics Corporation stock logo
BNP Paribas Financial Markets Buys 16,260 Shares of Haemonetics Co. (NYSE:HAE)
BNP Paribas Financial Markets grew its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 95.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 33,209 shares of the medical instruments supplier's stock after buying an additi
Haemonetics Corporation stock logo
Silvercrest Asset Management Group LLC Increases Stock Position in Haemonetics Co. (NYSE:HAE)
Silvercrest Asset Management Group LLC lifted its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 31.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 643,227 shares of the medical
Haemonetics Corporation stock logo
Haemonetics Co. (NYSE:HAE) Shares Sold by Numerai GP LLC
Numerai GP LLC trimmed its position in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 60.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,968 shares of the medical instruments supplier's stock after selling 9,11
Haemonetics Corporation stock logo
Prosight Management LP Sells 18,300 Shares of Haemonetics Co. (NYSE:HAE)
Prosight Management LP cut its holdings in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 28.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 46,700 shares of the medical instruments supplier's stock after selling
Haemonetics Corporation stock logo
LMR Partners LLP Makes New $2.06 Million Investment in Haemonetics Co. (NYSE:HAE)
LMR Partners LLP purchased a new stake in Haemonetics Co. (NYSE:HAE - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 26,365 shares of the medical instruments supplier's stock, valued at appro
Haemonetics Corporation stock logo
Haemonetics (NYSE:HAE) Downgraded to "Hold" Rating by StockNews.com
StockNews.com downgraded Haemonetics from a "buy" rating to a "hold" rating in a research note on Tuesday.
Haemonetics Corporation stock logo
London Co. of Virginia Has $22 Million Holdings in Haemonetics Co. (NYSE:HAE)
London Co. of Virginia raised its position in Haemonetics Co. (NYSE:HAE - Free Report) by 2.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 281,738 shares of the medical instruments supplier's stock afte
Haemonetics Corporation stock logo
49,250 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. acquired a new position in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 49,250 shares of the medical instruments supplier's stock, valued at approxi
Haemonetics Corporation stock logo
First Trust Advisors LP Has $328,000 Position in Haemonetics Co. (NYSE:HAE)
First Trust Advisors LP cut its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 83.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,198 shares of the medical instrument
Haemonetics Corporation stock logo
Expect Equity LLC Invests $1.10 Million in Haemonetics Co. (NYSE:HAE)
Expect Equity LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 14,100 shares of the medical instruments supplier's stock, valued at approximatel
Haemonetics Corporation stock logo
Haemonetics (NYSE:HAE) Releases FY 2026 Earnings Guidance
Haemonetics (NYSE:HAE) updated its FY 2026 earnings guidance. The company provided EPS guidance of 4.700-5.000 for the period, compared to the consensus estimate of 4.540.
Haemonetics Corporation stock logo
Axa S.A. Reduces Position in Haemonetics Co. (NYSE:HAE)
Axa S.A. decreased its position in Haemonetics Co. (NYSE:HAE - Free Report) by 11.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,400 shares of the medical instruments supplier's stock after selling 6,730 shares
Haemonetics Corporation stock logo
Northern Trust Corp Buys 93,848 Shares of Haemonetics Co. (NYSE:HAE)
Northern Trust Corp raised its stake in Haemonetics Co. (NYSE:HAE - Free Report) by 16.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 678,261 shares of the medical instruments supplier's stock after purchasing an additional 93,848 shares during the quart
Haemonetics Corporation stock logo
Brevan Howard Capital Management LP Grows Stake in Haemonetics Co. (NYSE:HAE)
Brevan Howard Capital Management LP raised its stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) by 404.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,810 shares of the medical
Haemonetics Corporation stock logo
5,065 Shares in Haemonetics Co. (NYSE:HAE) Acquired by Bridgefront Capital LLC
Bridgefront Capital LLC bought a new stake in shares of Haemonetics Co. (NYSE:HAE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 5,065 shares of the medical instruments supplier's stock, valued at approximately $395,000. O
Get Haemonetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter.

HAE Media Mentions By Week

HAE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HAE
News Sentiment

0.47

0.56

Average
Medical
News Sentiment

HAE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HAE Articles
This Week

4

6

HAE Articles
Average Week

Get Haemonetics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HAE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:HAE) was last updated on 6/19/2025 by MarketBeat.com Staff
From Our Partners